We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Denali Therapeutics
DNLI
$3.97B
| $426K | ﹤0.01% |
18,507
-2,395
| -11% | -$65.9K |
|
|
BRSL
902
Brightstar Lottery PLC
BRSL
$2.15B
| $426K | ﹤0.01% |
15,908
+1,551
| +11% | +$39.7K |
|
903
Paylocity
PCTY
$8.1B
| $425K | ﹤0.01% |
+2,139
| New | +$421K |
|
|
AEL
904
DELISTED
American Equity Investment Life Holding Company
AEL
| $425K | ﹤0.01% |
11,635
+1,511
| +15% | +$64.2K |
|
|
MODV
905
DELISTED
ModivCare
MODV
| $424K | ﹤0.01% |
5,040
-716
| -12% | -$68.9K |
|
906
Pennant Group
PNTG
$1.35B
| $422K | ﹤0.01% |
+29,520
| New | +$370K |
|
907
Flywire
FLYW
$2.22B
| $419K | ﹤0.01% |
14,283
-1,009
| -7% | -$26.6K |
|
908
First Financial Corp
THFF
$975M
| $418K | ﹤0.01% |
11,163
-308
| -3% | -$13.2K |
|
|
CWEN.A
909
DELISTED
Clearway Energy Class A
CWEN.A
| $416K | ﹤0.01% |
13,855
-22,233
| -62% | -$677K |
|
910
First Industrial Realty Trust
FR
$8.4B
| $414K | ﹤0.01% |
7,787
| – | – |
|
911
Protolabs
PRLB
$2.21B
| $412K | ﹤0.01% |
+12,430
| New | +$385K |
|
912
Teekay Tankers
TNK
$2.9B
| $412K | ﹤0.01% |
9,592
-26,108
| -73% | -$969K |
|
913
Ingersoll Rand
IR
$32.7B
| $411K | ﹤0.01% |
+7,072
| New | +$399K |
|
|
PVBC
914
DELISTED
Provident Bancorp
PVBC
| $410K | ﹤0.01% |
60,010
+14,901
| +33% | +$124K |
|
915
MediaAlpha
MAX
$813M
| $405K | ﹤0.01% |
+27,024
| New | +$366K |
|
916
Celanese
CE
$4.86B
| $403K | ﹤0.01% |
3,701
-7,658
| -67% | -$884K |
|
|
CHS
917
DELISTED
Chicos FAS, Inc.
CHS
| $402K | ﹤0.01% |
73,021
-165,787
| -69% | -$884K |
|
918
Match Group
MTCH
$8.56B
| $400K | ﹤0.01% |
+10,424
| New | +$455K |
|
919
Winmark
WINA
$1.26B
| $399K | ﹤0.01% |
1,245
-20
| -2% | -$5.6K |
|
920
AutoNation
AN
$6.89B
| $399K | ﹤0.01% |
2,967
-51,444
| -95% | -$6.6M |
|
921
Palantir
PLTR
$430B
| $398K | ﹤0.01% |
47,157
+35,681
| +311% | +$279K |
|
922
i3 Verticals
IIIV
$325M
| $396K | ﹤0.01% |
16,136
-440
| -3% | -$11.5K |
|
|
NATI
923
DELISTED
National Instruments Corp
NATI
| $395K | ﹤0.01% |
7,543
+940
| +14% | +$47.1K |
|
924
Tredegar Corp
TG
$278M
| $395K | ﹤0.01% |
43,270
-10,031
| -19% | -$111K |
|
925
T-Mobile US
TMUS
$197B
| $394K | ﹤0.01% |
2,720
-239
| -8% | -$34.6K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.